Edward Gabrielson

Bloomberg (United States)

Full Professor(heuristic)

Cancer Immunotherapy and Biomarkers · Oncology

Compare more Oncology professors.

h-index69
i10-index124
Publications290
Citations21,787

Grants

6 total · 0 active

NIH #P50CA058184

CB: Human Tissue and Pathology

Amount
$300K–$400K
Period
2008-10-01 → 2013-09-30
PIs
1

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #T32CA067751

Training Program in the Pathobiology of Cancer

Amount
$400K–$500K
Period
1996-07-01 → 2012-08-31
PIs
1

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #R01CA101232

A Metabolic Target for Lung Cancer Prevention

Amount
$500K–$600K
Period
2003-07-01 → 2007-06-30
PIs
1

Awarded at JOHNS HOPKINS UNIVERSITY

Active grants are a starting point, not proof of an opening. Confirm recruiting and funding with the professor, current students, and your written offer. Learn how to verify PhD funding →

All Grants

6 total · 0 active

NIH #P50CA058184

CB: Human Tissue and Pathology

Amount
$300K–$400K
Period
2008-10-01 → 2013-09-30
PIs
1

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #T32CA067751

Training Program in the Pathobiology of Cancer

Amount
$400K–$500K
Period
1996-07-01 → 2012-08-31
PIs
1

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #R01CA101232

A Metabolic Target for Lung Cancer Prevention

Amount
$500K–$600K
Period
2003-07-01 → 2007-06-30
PIs
1

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #R21CA081442

MICROSATELLITE MARKERS OF DCIS PROGNOSIS

Amount
$100K–$200K
Period
1999-07-01 → 2002-04-30
PIs
1

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #P30CA006973

CORE--HUMAN TISSUE AND PATHOLOGY FACILITY

Amount
$300K–$400K
Period
1998-06-15 → 1999-04-30
PIs
1

Awarded at JOHNS HOPKINS UNIVERSITY

NIH #S07RR005378

MOLECULAR BIOLOGY OF MESOTHELIOMA AUTOCRINE GROWTH FACTORS

Amount
—
Period
— → —
PIs
1

Awarded at JOHNS HOPKINS UNIVERSITY

Recent Public Signals

  1. New paper: Supplementary Figure S7 from Gallium-68–labeled Peptide PET Quantifies Tumor Exposure of PD-L1 Therapeutics2025-11-25
  2. New preprint: CRYβB2 is a biomarker for poor prognosis and response to CDK4/6 inhibitors in breast cancer2025-05-07

Are you this professor?

No account needed — verify once with your ORCID iD to set recruiting status and correct your rank.

Data Freshness

  • Publications as of 2026-07-09
  • Grants as of 2026-09-03

Data may not be current

Find elsewhere

Institution / lab homepage Search on ResearchGate

ORCID: 0000-0001-5879-7321

Professor Insights

Career Trajectory